Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726193 · ClinicalTrials.gov registry record
Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 4
- Enrollment target
NCT00726193 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 4 participants.
The verdict
NCT00726193 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this clinical outcomes collection study is to analyze the effect of the EBI OsteoGen™ Direct Current Stimulator upon surgical reconstruction of tibia nonunion (no visible progressive signs of healing) fracture in a prospective database.
Interventions
- DEVICE OsteoGen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726193
The ClinicalTrials.gov registry entry for NCT00726193 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OsteoGen is the first listed.
NCT00726193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726193 about?
NCT00726193 is a clinical study titled "Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions". The purpose of this clinical outcomes collection study is to analyze the effect of the EBI OsteoGen™ Direct Current Stimulator upon surgical reconstruction of tibia nonunion (no visible progressive signs of healing) fracture in a prospective database.
What is the current status of trial NCT00726193?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2006-06. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00726193?
The interventions under investigation include: OsteoGen (DEVICE).
Who is sponsoring clinical trial NCT00726193?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.